BPO 0.00% 0.3¢ bioprospect limited

further news

  1. 1,731 Posts.
    I have been mentioning for about a week that good news was forthcoming re BPO. It isn't finnished yet, that was only an sample. There is more to come re core business matters and QCIDE and or the prostate cancer drug.

    Will post again Friday if I can find a bit more inside drum from my source. Still good value under 15c, don't miss the Biotech boat on this one.
 
watchlist Created with Sketch. Add BPO (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.